Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human kallikrein-related peptidase 2 (hK2/KLK2) is a secreted serine protease mainly produced by the prostate. It acts together with PSA/KLK3 to facilitate semen liquefaction through specific protein cleavage events. Its unique structural features—especially the flexible “99-loop”—contribute to its enzymatic specificity and regulation. Given its highly restricted expression profile, it serves as both a biological marker for prostate health/disease states and an attractive target for therapeutic intervention or diagnostic development.
Inhibition of serine protease activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Kallikrein-Related Peptidase 2 (hK2).